Cerebellar ataxia by enhanced Cav2.1 currents is alleviated by Ca2+-dependent K-channel activators in Cacna1aS218l mutant mice

Mutations in the CACNA1A gene are associated with neurological disorders, such as ataxia, hemiplegic migraine, and epilepsy. These mutations affect the pore-forming α1A-subunit of CaV2.1 channels and thereby either decrease or increase neuronal Ca2+ influx. A decreased CaV2.1-mediated Ca2+ influx has been shown to reduce the regularity of cerebellar Purkinje cell activity and to induce episodic cerebellar ataxia. However, little is known about how ataxia can be caused by CACNA1A mutations that increase the Ca2+ influx, such as the S218L missense mutation. Here, we demonstrate that the S218L mutation causes a negative shift of voltage dependence of CaV2.1 channels of mouse Purkinje cells and results in lowered thresholds for somatic action potentials and dendritic Ca2+ spikes and in disrupted firing patterns. The hyperexcitability of Cacna1aS218L Purkinje cells was counteracted by application of the activators of Ca2+-dependent K+ channels, 1-EBIO and chlorzoxazone (CHZ). Moreover, 1-EBIO also alleviated the irregularity of Purkinje cell firing both in vitro and in vivo, while CHZ improved the irregularity of Purkinje cell firing in vitro as well as the motor performance of Cacna1aS218L mutant mice. The current data suggest that abnormalities in Purkinje cell firing contributes to cerebellar ataxia induced by the S218L mutation and they advocate a general therapeutic approach in that targeting Ca2+-dependent K+ channels may be beneficial for treating ataxia not only in patients suffering from a decreased Ca2+ in their Purkinje cells.

• View at Publisher
• View at Pubmed
• View at Scopus
• View at Web of Science